{"created":"2023-05-15T14:47:59.488727+00:00","id":65775,"links":{},"metadata":{"_buckets":{"deposit":"5a652fcc-fad0-4dc8-a3e1-eefc1b066b1a"},"_deposit":{"created_by":1,"id":"65775","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"65775"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00065775","sets":["10:29"]},"author_link":["647908","647909"],"item_10005_date_7":{"attribute_name":"発表年月日","attribute_value_mlt":[{"subitem_date_issued_datetime":"2015-09-18","subitem_date_issued_type":"Issued"}]},"item_10005_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Sarcoidosis Immune Granulomas formation in various organ Unknown cause, genetic susceptibility and environmental facors Epidemiology：4.7-64/10 million,Scandinavian 50-60/10 million, Japan 1-2/10 million Peak onset：age 20-39 Outcome：death rate <5%（Pulmonary fibrosis・cardiac・neurologic involvement）\nSummary\nPatients with pulmonary sarcoidosis: 9.3% had cardiac involvement, require CS detection in this population RV evaluation: specific for CS FDG PET: Need to establish standard (JSNC guidelines) Useful for evaluate steroid treatment effects\n   Need further prospective studies","subitem_description_type":"Abstract"}]},"item_10005_description_6":{"attribute_name":"会議概要（会議名, 開催地, 会期, 主催者等）","attribute_value_mlt":[{"subitem_description":"the 20th Annual Scientific Session of the American Society of Nuclear Cardiology ","subitem_description_type":"Other"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Yoshinaga, Keiichiro"}],"nameIdentifiers":[{"nameIdentifier":"647908","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"吉永 恵一郎","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"647909","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"conference object","resourceuri":"http://purl.org/coar/resource_type/c_c94f"}]},"item_title":"Important Roles of Nuclear Cardiology in Cardiac Sarcoidosis","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Important Roles of Nuclear Cardiology in Cardiac Sarcoidosis"}]},"item_type_id":"10005","owner":"1","path":["29"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-09-29"},"publish_date":"2015-09-29","publish_status":"0","recid":"65775","relation_version_is_last":true,"title":["Important Roles of Nuclear Cardiology in Cardiac Sarcoidosis"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T20:56:24.265434+00:00"}